Some studies have shown:

• Slowed cognitive decline in people with Alzheimer's disease
• Can clear amyloid beta plaques, which are a hallmark of Alzheimer's disease 
• Can improve memory and executive function in people with Alzheimer's disease
• Reduce inflammation in the brain
• Protect neurons from damage
• Improve blood flow to the brain
• May have potential to prevent Alzheimer's disease

• On average, users can expect to lose 5-15% of their body weight over a year of treatment
• Some individuals may lose even more weight
• Slowing down gastric emptying, making individuals feel full for longer
• Reducing hunger and cravings
• Stimulating insulin release, which helps lower blood sugar levels
• If weight loss is Not a goal, we can tailor the medication dose for you to help avoid that

• GLP1s can help reduce insulin resistance and improve blood sugar levels
• GLP1s stimulate the pancreas to release more insulin, which helps lower blood sugar levels
• Reduce the production of fatty acids in the liver and promotes the breakdown of fat cells
• May help treat nonalcoholic fatty liver disease (NAFLD)
• May improve mood symptoms in people with anxiety and depression
• May suppress cravings for alcohol
• May reduce cravings in opiate addiction